YS Biopharma Co Ltd
NASDAQ:LSB

Watchlist Manager
YS Biopharma Co Ltd Logo
YS Biopharma Co Ltd
NASDAQ:LSB
Watchlist
Price: 3.08 USD -8.06% Market Closed
Market Cap: 58.8m USD
Have any thoughts about
YS Biopharma Co Ltd?
Write Note

Gross Margin
YS Biopharma Co Ltd

79.5%
Current
45%
Average
63.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
79.5%
=
Gross Profit
455.7m
/
Revenue
573.4m

Gross Margin Across Competitors

Country CN
Market Cap 58.8m USD
Gross Margin
79%
Country US
Market Cap 334.6B USD
Gross Margin
67%
Country US
Market Cap 172.7B USD
Gross Margin
63%
Country US
Market Cap 125.3B USD
Gross Margin
86%
Country US
Market Cap 111.4B USD
Gross Margin
87%
Country US
Market Cap 108.2B USD
Gross Margin
77%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 145.3B AUD
Gross Margin
52%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country US
Market Cap 38.1B USD
Gross Margin
87%
Country KY
Market Cap 248.5B CNY
Gross Margin
84%

Profitability Report

View the profitability report to see the full profitability analysis for YS Biopharma Co Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
79.5%
=
Gross Profit
455.7m
/
Revenue
573.4m
What is the Gross Margin of YS Biopharma Co Ltd?

Based on YS Biopharma Co Ltd's most recent financial statements, the company has Gross Margin of 79.5%.